Factors controlling the circulating CEA levels in pancreatic cancer: Some clinical correlations

Cancer

Volumn 47, Issue 6 S, 1981, Pages 1620-1627

  Zamcheck, Norman ^a,b,c,d   Martin, Edward W ^a,b,c,d  

^a BOSTON MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; ARTICLE; CASE REPORT; EXTRAHEPATIC BILE DUCT OBSTRUCTION; FEMALE; HUMAN; LIVER DISEASE; MALE; PANCREAS DUCT; PANCREAS RESECTION; PANCREAS TUMOR; PROGNOSIS; TIME;

ADULT; BILE DUCT OBSTRUCTION, EXTRAHEPATIC; CARCINOEMBRYONIC ANTIGEN; CASE REPORT; FEMALE; HUMAN; LIVER DISEASES; MALE; MIDDLE AGE; PANCREATECTOMY; PANCREATIC DUCTS; PANCREATIC NEOPLASMS; PROGNOSIS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS;

EID: 0019880568     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19810315)47:6+<1620::AID-CNCR2820471426>3.0.CO;2-D     Document Type: Article

References (34)

1. The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins
2. Initial levels of CEA and their rate of change in pancreatic carcinoma following surgery, chemotherapy and radiation therapy
3. (for the Gastrointestinal Tumor Study Group). Prognostic factors in pancreatic carcinoma
4. Cancer of the pancreas: palliative operation, Whipple procedure, or total pancreatectomy?
5. Prospective evaluation of the pancreatic secretion of immunoreactive carcinoembryonic antigen, enzyme, and bicarbonate in patients suspected of having pancreatic cancer
6. Carcinoembryonic antigen in pancreatitis
7. CEA in gastrointestinal and extragastrointestinal tumors and its relation to tumor cell differentiation
8. (for the Gastrointestinal Tumor Study Group). Delayed hypersensitivity skin testing (DHS), total lymphocyte counts (TLC) and CEA levels in patients with gastric and pancreatic cancer
9. Study of reticuloendothelial phagocytic capacity in patients with cholestasis
10. Free and bound carcinoembryonic antigen in neoplasms and in normal adult and fetal tissue
11. Immunocytochemical detection of carcinoembryonic antigen in conventional histopathology specimens
12. Circulating carcinoembryonic antigen in pancreatic cancer
13. Carcinoembryonic antigen in serum in diseases of the liver and pancreas
14. Carcinoembryonic antigen: The most accurate noninvasive diagnostic test for predicting malignancy in the jaundiced patient
15. Duodenal carcinoembryonic antigen in patients with benign and malignant diseases: Preliminary observations
16. Carcinoma of the pancreas
17. Elevated carcinoembryonic antigen levels and biliary tract obstruction
18. Radioimmunoassay of carcinoembryonic antigen in extracts of human colon stomach
19. Antineoplastic agents and the liver
20. Carcinoembryonic antigen(s) in liver disease. I. Clinical and morphological studies
21. Carcinoembryonic antigen assay in cancer of the colon and pancreas and other digestive tract disorders
22. Cholestasis and hepatic metastases: A factor contributing to very high plasma carcinoembryonic antigen (CEA) elevations
23. Carcinoembryonic antigen (CEA) in the diagnosis of pancreatic cancer
24. Immunoperoxidase detection of carcinoembryonic antigen. An overview
25. Usefulness of serial serum carcinoembryonic antigen (CEA) determinations during anticancer therapy or long‐term followup of gastrointestinal carcinoma
26. Carcinoembryonic antigen (CEA) activity in pancreatic juice of patients with pancreatic carcinoma and pancreatitis
27. Carcinoembryonic antigen: Clinical correlation with chemotherapy for metastatic gastrointestinal cancer
28. A radioautographic study of the hepatic uptake of circulating carcinoembryonic antigen by the mouse
29. The biliary excretion of circulating asialoglycoproteins in the rat
30. Histopathology in the evaluation of total pancreatectomy for ductal carcinoma
31. Studies on the mechanism of CEA elevations in patients with liver diseases
32. The prospective evaluation of tumour‐associated antigens for the early diagnosis of pancreatic cancer
33. Immunologic diagnosis and prognosis of human digestive‐tract cancer: Carcinoembryonic Antigen
34. The present status of carcinoembryonic antigen (CEA) in diagnosis, detection of recurrence, prognosis and evaluation of therapy of colonic and pancreatic cancer